Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00305305
Status:
RECRUITING
Last Update Posted:
2023-10-10
First Post:
2006-03-17
Brief Title:
Brain Development Research Program
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Study Overview
Official Title:
Disorders of Cerebral Development A Phenotypic and Genetic Analysis
Status:
RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dr Elliott Sherr and his collaborators at University of California San Francisco UCSF are studying the genetic causes of disorders of cognition and epilepsy in particular disorders of brain development that affect the corpus callosum such as Aicardi syndrome as well as two additional brain malformations polymicrogyria and Dandy-Walker malformation The goal of the investigators research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients
Detailed Description:
We are studying both the genetics and clinical features of these disorders We hope to understand the problems faced by individuals with these disorders as well as their causes In the future we hope to develop therapies that are geared specifically for individuals based on the underlying biology To participate in the study you will be asked to provide a copy of the magnetic resonance imaging MRI documenting Agenesis Corpus Callosum ACC Polymicrogyria PMG or Dandy-Walker malformation DWM clinical information and saliva or blood samples from the affected individual and from the parents Please see contact information and our webpage below
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None